Extension Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Clinical trial NCT03281538 · COMPLETED
Trial details
- NCT number
- NCT03281538
- Sponsor
- Cara Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-14
- Primary completion
- 2020-02-11
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.